LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Publicacions (475) Publicacions en què ha participat algun/a investigador/a
2024
-
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
npj Parkinson's Disease, Vol. 10, Núm. 1
-
Automated procedure to detect subtle motor alterations in the balance beam test in a mouse model of early Parkinson’s disease
Scientific Reports, Vol. 14, Núm. 1
-
Designing Virtual Coaching Solutions: Design and Evaluation of a Digital Health Intervention for Rehabilitation
Business and Information Systems Engineering, Vol. 66, Núm. 3, pp. 377-400
-
Implication of nutrition in severity of symptoms and treatments in quality of life in Parkinson’s disease: a systematic review
Frontiers in Nutrition, Vol. 11
-
Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance
European Neuropsychopharmacology
-
Machine Learning for Prediction of Cognitive Deterioration in Patients with Early Parkinson’s Disease
Applied Sciences (Switzerland), Vol. 14, Núm. 18
-
Medication impact on oral health in schizophrenia
Medicina Oral Patologia Oral y Cirugia Bucal, Vol. 29, Núm. 1, pp. e51-e57
-
Plasma Neurofilament Light Chain: A Potential Biomarker for Neurological Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Biomedicines, Vol. 12, Núm. 7
-
Predicting Parkinson’s Disease Progression: Analyzing Prodromal Stages Through Machine Learning
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)
-
Prognostic factors for falls in Parkinson’s disease: a systematic review
Acta Neurologica Belgica, Vol. 124, Núm. 2, pp. 395-406
-
Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
Neuron, Vol. 112, Núm. 17, pp. 2886-2909.e16
-
Reactive antibodies against brain antigens as serological biomarkers of neurodegenerative diseases
Advanced Neurology, Vol. 3, Núm. 1
-
Retraction note: Cardiac Arrest Alters Regional Ubiquitin Levels in Association with the Blood–Brain Barrier Breakdown and Neuronal Damages in the Porcine Brain (Molecular Neurobiology, (2015), 52, 2, (1043-1053), 10.1007/s12035-015-9254-7)
Molecular Neurobiology
-
Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders
International Journal of Molecular Sciences, Vol. 25, Núm. 4
-
Understanding the olfactory role in post-COVID cognitive and neuropsychiatric manifestations
Frontiers in Psychology, Vol. 15
-
Virtual Coaching for Home Rehabilitation - Evidence of an Empirical Study
Studies in health technology and informatics, Vol. 316, pp. 147-151
2023
-
Abordaje multidisciplinar y difusión social de un problema sanitario
Revista de innovación y buenas prácticas docentes, Vol. 12, Núm. 2, pp. 13-25
-
Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database
European Journal of Clinical Pharmacology, Vol. 79, Núm. 5, pp. 679-685
-
Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study
Biomedicines, Vol. 11, Núm. 2
-
Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles
Neurochemical Research, Vol. 48, Núm. 6, pp. 1864-1888